CID 135564930

Hydroxyacetildenafil

Structural Information

Molecular Formula
C25H34N6O4
SMILES
CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)C(=O)CN4CCN(CC4)CCO)OCC)C
InChI
InChI=1S/C25H34N6O4/c1-4-6-19-22-23(29(3)28-19)25(34)27-24(26-22)18-15-17(7-8-21(18)35-5-2)20(33)16-31-11-9-30(10-12-31)13-14-32/h7-8,15,32H,4-6,9-14,16H2,1-3H3,(H,26,27,34)
InChIKey
RZVZQPAGIOECPK-UHFFFAOYSA-N
Compound name
5-[2-ethoxy-5-[2-[4-(2-hydroxyethyl)piperazin-1-yl]acetyl]phenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

2
References

69
Patents

482.26416 Da
Monoisotopic Mass

1.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 483.27144 222.3
[M+Na]+ 505.25338 229.0
[M-H]- 481.25688 222.8
[M+NH4]+ 500.29798 223.0
[M+K]+ 521.22732 220.9
[M+H-H2O]+ 465.26142 209.6
[M+HCOO]- 527.26236 230.3
[M+CH3COO]- 541.27801 237.0
[M+Na-2H]- 503.23883 218.0
[M]+ 482.26361 224.6
[M]- 482.26471 224.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe